Davita Inc. Stock
Davita Inc. Stock
Davita Inc. gained 0.550% compared to yesterday.
Our community identified positive and negative aspects for Davita Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Davita Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Davita Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Davita Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Davita Inc. | 0.550% | -2.798% | -3.589% | -35.167% | -31.205% | 44.797% | 11.795% |
| Ensign Group Inc. | -1.300% | -5.556% | -4.375% | 10.072% | 20.472% | - | - |
| Amn Healthcare Svs | 1.440% | -4.054% | -16.959% | -45.802% | -37.719% | -87.863% | -73.458% |
| Chemed Corp. | -0.550% | -2.660% | -3.684% | -32.222% | -26.506% | - | - |
Comments
DaVita (NYSE:DVA) had its price target lowered by analysts at Bank of America Corporation from $145.00 to $140.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at UBS Group AG from $169.00 to $175.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at Bank of America Co. from $139.00 to $145.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat